Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $45.7800 (-2.51%) ($45.7800 - $45.7800) on Tue. Mar. 2, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.22% (three month average) | RSI | 17 | Latest Price | $45.7800(-2.51%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -1.4% a day on average for past five trading days. | Weekly Trend | EDIT declines -11.8% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(62%) IWC(60%) IBUY(59%) IWM(57%) | Factors Impacting EDIT price | EDIT will decline at least -4.11% in a week (0% probabilities). VIXM(-31%) UUP(-16%) VXX(-13%) TBT(-7%) IGOV(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.11% (StdDev 8.22%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $25.36(-44.6%) | Resistance Level | $55.65 | 5 Day Moving Average | $46.16(-0.82%) | 10 Day Moving Average | $49.75(-7.98%) | 20 Day Moving Average | $55.65(-17.74%) | To recent high | -49.6% | To recent low | 45% | Market Cap | $2.843b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |